145 related articles for article (PubMed ID: 16268485)
1. CpG methylation of the PAI-1 gene 5'-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines.
Gao S; Skeldal S; Krogdahl A; Sørensen JA; Andreasen PA
Thromb Haemost; 2005 Sep; 94(3):651-60. PubMed ID: 16268485
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.
Claus R; Fliegauf M; Stock M; Duque JA; Kolanczyk M; Lübbert M
J Leukoc Biol; 2006 Dec; 80(6):1462-72. PubMed ID: 17000900
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa.
Gao S; Nielsen BS; Krogdahl A; Sørensen JA; Tagesen J; Dabelsteen S; Dabelsteen E; Andreasen PA
Genes Chromosomes Cancer; 2010 Jun; 49(6):526-38. PubMed ID: 20222049
[TBL] [Abstract][Full Text] [Related]
6. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypomethylation contributes to the expression of MUC3A in cancer cells.
Kitamoto S; Yamada N; Yokoyama S; Houjou I; Higashi M; Yonezawa S
Biochem Biophys Res Commun; 2010 Jun; 397(2):333-9. PubMed ID: 20510874
[TBL] [Abstract][Full Text] [Related]
8. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
12. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
Bai T; Tanaka T; Yukawa K; Umesaki N
Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
[TBL] [Abstract][Full Text] [Related]
13. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
14. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J
Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977
[TBL] [Abstract][Full Text] [Related]
15. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.
Toyooka S; Fukuyama Y; Wistuba II; Tockman MS; Minna JD; Gazdar AF
Clin Cancer Res; 2002 Jul; 8(7):2292-7. PubMed ID: 12114433
[TBL] [Abstract][Full Text] [Related]
17. Methylation silencing of the Apaf-1 gene in acute leukemia.
Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
19. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]